BEYOND AIR INC. - COMMON STOCK

Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

27 Jul 2022 16:05:01 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022

28 Jun 2022 16:10:00 By Nasdaq GlobeNewswire

Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

28 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th

14 Jun 2022 16:30:00 By Nasdaq GlobeNewswire

Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer

01 Jun 2022 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

17 May 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

17 May 2022 07:00:02 By Nasdaq GlobeNewswire

Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

16 May 2022 07:05:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

25 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Beyond Air® to Participate in Three Upcoming Medical Conferences

18 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

11 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

08 Mar 2022 16:35:00 By Nasdaq GlobeNewswire

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022

10 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022

08 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors

03 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast

27 Jan 2022 08:00:03 By Nasdaq GlobeNewswire

Beyond Air® Provides Regulatory Update for LungFit® PH

09 Dec 2021 08:30:00 By Nasdaq GlobeNewswire

Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer

01 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement

18 Nov 2021 16:05:00 By Nasdaq GlobeNewswire